glioma of WHO Grade III or IV
Showing 1 - 25 of >10,000
High Grade Glioma, Glioblastoma Trial in Cleveland (Standard Surgical Treatment, Intraoperative Electrocorticography)
Not yet recruiting
- High Grade Glioma
- Glioblastoma
- Standard Surgical Treatment
- Intraoperative Electrocorticography
-
Cleveland, OhioCleveland Clinic Taussig Cancer Institute, Case Comprehensive Ca
Sep 30, 2022
Grade III or Grade IV Glioma Trial (PET imaging with 18F fluciclovine)
Not yet recruiting
- Grade III or Grade IV Glioma
- PET imaging with 18F fluciclovine
- (no location specified)
Jul 27, 2022
Glioma, Anaplastic Astrocytoma, Anaplastic Oligodendroglioma Trial in Duarte, Chicago (Neural stem cells loaded with an
Completed
- Glioma
- +7 more
- Neural stem cells loaded with an oncolytic adenovirus
-
Duarte, California
- +1 more
Dec 28, 2022
Supramaximal Resection Versus Maximal Resection for High-Grade
Recruiting
- Glioblastoma
- +11 more
- Supramaximal resection
- Maximal safe resection
-
San Francisco, California
- +7 more
Nov 1, 2023
Targeted Pediatric High-Grade Glioma Therapy
Not yet recruiting
- High Grade Glioma
- +8 more
-
Aurora, Colorado
- +17 more
May 1, 2023
High Grade Glioma Trial in Basel (endurance training, social support and counseling, resistance training)
Completed
- High Grade Glioma
- endurance training
- +2 more
-
Basel, Switzerland
- +1 more
May 17, 2022
High Grade Glioma, Diffuse Intrinsic Pontine Glioma, Anaplastic Astrocytoma Trial in Worldwide (Ribociclib, Everolimus)
Not yet recruiting
- High Grade Glioma
- +8 more
-
Aurora, Colorado
- +17 more
May 2, 2023
Glioblastoma, Astrocytoma, Grade III, Astrocytoma, Grade IV Trial in Lake Success (Stereotactic Radiosurgery)
Active, not recruiting
- Glioblastoma
- +3 more
- Stereotactic Radiosurgery
-
Lake Success, New YorkNorthwell Health Brain Tumor Center
Feb 3, 2022
Glioblastoma, WHO Grade II Glioma, WHO Grade III Glioma Trial in Philadelphia (Intensity-Modulated Radiation Therapy,
Recruiting
- Glioblastoma
- +2 more
- Intensity-Modulated Radiation Therapy
- Quality-of-Life
-
Philadelphia, PennsylvaniaSidney Kimmel Cancer Center at Thomas Jefferson University
Jun 3, 2021
Recurrent World Health Organization (WHO) Grade II Glioma, Recurrent WHO Grade III Glioma, WHO Grade II Glioma Trial in San
Recruiting
- Recurrent World Health Organization (WHO) Grade II Glioma
- +3 more
- Hyperpolarized Carbon C 13 Pyruvate
- +2 more
-
San Francisco, CaliforniaUniversity of California, San Francisco
Dec 21, 2022
Grade II Glioma, Grade III Glioma, Grade IV Glioma Trial in Boston (Microdevice)
Recruiting
- Grade II Glioma
- +7 more
- Microdevice
-
Boston, MassachusettsBrigham and Women's Hospital
Feb 22, 2021
Malignant Glioma, Glioblastoma Trial in Durham (hEGFRvIII-CD3 (BRiTE), Activated Cell Therapy)
Not yet recruiting
- Malignant Glioma
- Glioblastoma
- hEGFRvIII-CD3 (BRiTE)
- Activated Cell Therapy
-
Durham, North CarolinaDuke University Medical Center
Jun 24, 2022
Glioblastoma Multiforme Trial in Los Angeles, Cleveland (Perillyl alcohol)
Recruiting
- Glioblastoma Multiforme
- Perillyl alcohol
-
Los Angeles, California
- +1 more
Sep 23, 2022
Vascular Habitats Within Astrocytoma Grade 4 at Molecular,
Recruiting
- Astrocytoma, Grade IV
- +7 more
-
Valencia, SpainBiomedical Data Science Lab. Universitat Politècnica de València
May 11, 2022
Anaplastic Astrocytoma, IDH-Wildtype, Anaplastic Oligoastrocytoma, Anaplastic Oligodendroglioma Trial in Houston (other,
Recruiting
- Anaplastic Astrocytoma, IDH-Wildtype
- +8 more
- Quality-of-Life Assessment
- +3 more
-
Houston, TexasM D Anderson Cancer Center
Dec 8, 2022
Recurrent Anaplastic Astrocytoma, Recurrent Anaplastic Oligoastrocytoma, Recurrent Anaplastic Oligodendroglioma Trial in Duarte
Withdrawn
- Recurrent Anaplastic Astrocytoma
- +7 more
- Neural Stem Cells-expressing CRAd-S-pk7
- Resection
- (no location specified)
Nov 22, 2022
GBM, Glioblastoma, Glioma Trial in Durham (Recombinant nonpathogenic polio-rhinovirus chimera (PVSRIPO))
Completed
- GBM
- +3 more
- Recombinant nonpathogenic polio-rhinovirus chimera (PVSRIPO)
-
Durham, North CarolinaDuke University Medical Center
Jun 28, 2022
Grade III Astrocytoma, Grade IV Astrocytoma, Astrocytoma, Grade IV Trial in Saint Louis (Tadalafil)
Active, not recruiting
- Grade III Astrocytoma
- +3 more
-
Saint Louis, MissouriWashington University School of Medicine
Jun 9, 2022
Glioblastoma, Glioma, Glioblastoma Multiforme Trial in Phoenix (AZD1390)
Recruiting
- Glioblastoma
- +3 more
-
Phoenix, ArizonaSt. Joseph's Hospital and Medical Center
Mar 10, 2022
Glioblastoma, Malignant Glioma, Recurrent Glioblastoma Trial in Worldwide (biological, drug, other)
Recruiting
- Glioblastoma
- +5 more
- Ipilimumab
- +4 more
-
Birmingham, Alabama
- +19 more
Aug 16, 2022
Glioma, Glioblastoma Trial in Winston-Salem (Soliramfetol)
Recruiting
- Glioma
- Glioblastoma
-
Winston-Salem, North CarolinaWake Forest Baptist Comprehensive Cancer Center
Jan 31, 2022
Malignant Glioma Trial in United States (PVSRIPO)
Active, not recruiting
- Malignant Glioma
- PVSRIPO
-
San Francisco, California
- +5 more
Jun 28, 2022
Glioblastoma Trial in Durham (Human CMV pp65-LAMP mRNA-pulsed autologous DCs containing GM CSF, Temozolomide, Tetanus-Diphtheria
Suspended
- Glioblastoma
- Human CMV pp65-LAMP mRNA-pulsed autologous DCs containing GM CSF
- +4 more
-
Durham, North CarolinaDuke University Medical Center
Aug 16, 2022
Intracranial Tumor, Low Grade Glioma, Recurrent Glioblastoma Trial in San Francisco (F-18 Fluoroethyltyrosine (FET), Positron
Recruiting
- Intracranial Neoplasm
- +4 more
- F-18 Fluoroethyltyrosine (FET)
- Positron Emission Tomography (PET)
-
San Francisco, CaliforniaUniversity of California, San Francisco
Nov 7, 2022